Biocompatible and bioactive PVA/Sericin/Chitosan nanofibrous wound dressing matrix
This work focuses on preparation of electrospun matrix for wound dressing application by utilizing sericin, chitosan and silver nanoparticles in PVA nanofibers. Sericin (SS) is extracted from silk cocoon (Bombyx Mori) by alkali degumming method. The extracted sericin is characterised by UV-visible S...
Gespeichert in:
Veröffentlicht in: | Applied surface science advances 2023-02, Vol.13, p.100362, Article 100362 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | This work focuses on preparation of electrospun matrix for wound dressing application by utilizing sericin, chitosan and silver nanoparticles in PVA nanofibers. Sericin (SS) is extracted from silk cocoon (Bombyx Mori) by alkali degumming method. The extracted sericin is characterised by UV-visible Spectroscopy and FT-IR. Then, individual stock solutions of 2% (w/v) Chitosan (CH) in acetic acid, 10% (w/v) of PVA in deionised water were prepared. To enhance the antimicrobial property to the wound dressing, silver nanoparticles (Ag NP) was prepared using Cynodan dactylon (Bermuda grass) leaves extract and characterised using UV-visible Spectroscopy. The prepared Ag NP was incorporated in the nanofibers at constant proportion. Furthermore, three blended PVA/SS/CH solutions were prepared in the following ratios 8:1:1, 5:2.5:2.5, and 2:4:4 and electrospun to create nanofibrous dressing material. The structural and physical characteristics of the prepared nanofibrous dressing material were studied using SEM and Universal Testing Machine. Based upon mechanical strength and SEM analysis PVA/SS/CH in the ratio 8:1:1 was chosen for In-vitro studies. From the studies it concludes that the prepared PVA/SS/CH electrospun nanofiber will be a promising material for wound dressing. |
---|---|
ISSN: | 2666-5239 2666-5239 |
DOI: | 10.1016/j.apsadv.2022.100362 |